New peripheral venous and arterial crossing tool paves a path to Europe SALT LAKE CITY, Feb. 06, 2020 (GLOBE NEWSWIRE) — XableCath, Inc., announced its XableCath™ Crossing Catheters have received CE Mark for peripheral use. Its crossing devices will be available for sale in Europe in two versions, a blunt […]
Author: Ken Dropiewski
Teleflex Announces Fourth Quarter and Full Year 2019 Earnings Conference Call Information
WAYNE, Pa., Feb. 06, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) announced today that financial results for the fourth quarter and full year 2019 will be released before market open on Thursday, February 20, 2020. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, February […]
Cardiovascular Systems, Inc. Reports Fiscal 2020 Second-Quarter Financial Results
Conference Call Scheduled for Today, February 5, 2020, at 3:30 PM CT (4:30 PM ET) Revenues of $68.3 million increased 13.5% from second quarter last year Net loss was $3.4 million, or $0.10 per basic and diluted share Company raises low end of fiscal 2020 revenue guidance range ST. PAUL, […]
Surmodics Reports First Quarter Fiscal 2020 Results
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2020 first quarter ended December 31, 2019. Summary of First Quarter and Recent Highlights Revenue of $22.6 million, an increase of 2% […]
Abiomed Announces Q3 FY 2020 Revenue of $222 Million and 31.7% Operating Margin
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported third quarter fiscal 2020 revenue of $221.6 million, an increase of 10% compared to revenue of $200.6 million for the same period of fiscal 2019. Operating income was $70.3 million, up 13%, compared […]
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Period Activity
− Achieved Fourth Quarter and Full Year 2019 ONPATTRO® (patisiran) Global Net Product Revenues of $55.8 Million and $166.4 Million, Respectively – − As of Year-End 2019, Over 750 Patients Worldwide Receiving Commercial ONPATTRO, with Over 1,000 Total Patients Worldwide Being Treated with Patisiran – – Observed Strong Initial Demand for […]
BioVentrix Receives 2020 NUB Reimbursement Status 1 Renewal in Germany for the Revivent TC TransCatheter Ventricular Enhancement System
SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., developer of the first transcatheter device for left ventricular remodeling after a heart attack, today announced it received renewal of the highest priority reimbursement in Germany for the Revivent TC™ TransCatheter Ventricular Enhancement System by achieving the NUB Status 1 designation from InEk, the German […]
Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results for 2019
NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today reports results for the fourth quarter and full year of 2019, which highlight continued strong sales and robust operating performance, along with the ongoing advancement of the company’s pipeline. “By all measures, 2019 was a transformative year for Bristol-Myers Squibb as we progressed our […]
AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has appointed Stephen Trowbridge to the role of Executive Vice President and Chief Financial Officer, effective February 5, 2020. Mr. Trowbridge has served […]
Enrollment of the VasQ™ External Support US Pivotal Study Now Complete
TEL AVIV, Israel, Feb. 4, 2020 /PRNewswire/ — Laminate Medical Technologies (Laminate) has announced the completion of enrollment into the VasQ™ External Support US Pivotal Study. The study was conducted at 17 sites across the U.S. and prospectively enrolled 144 male and female patients in need of an arteriovenous fistula (AVF) for […]



